Medical information Clinical review pending

Genetic Testing

Preimplantation Genetic Disorder PGD Single Gene Disorder Known Mutation Baseline

Preimplantation Genetic Disorder (PGD) testing for couples undergoing IVF to screen embryos for known single-gene disorders before implantation, helping to prevent hereditary diseases.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Peripheral blood samples from both parents and, if available, an affected child. Embryo biopsy performed during the IVF cycle.
Results: Confirm with the laboratory before booking.
Preparation: Consultation with a physician and genetic counselor is required before testing. This test is performed in conjunction with an IVF cycle. No specific patient preparation is needed for the blood draw, but follow standard instructions provided by the laboratory.

Test priceKSh 90,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Preimplantation Genetic Disorder PGD Single Gene Disorder Known Mutation Baseline test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Couples undergoing IVF with a known family history of a specific single-gene disorder.
✓Individuals undergoing IVF who are carriers of a known single-gene disorder.
✓Couples who have previously had a child affected by a specific single-gene disorder.
✓Individuals seeking to prevent the transmission of a known genetic condition to their children.

In plain language

What this test helps you understand

This test helps couples undergoing IVF identify embryos affected by a known single-gene disorder, allowing for the selection of unaffected embryos for transfer, thereby reducing the risk of transmitting the disorder to offspring.

Preimplantation Genetic Disorder (PGD) testing is a specialized procedure for individuals undergoing in vitro fertilization (IVF). It is designed to identify specific genetic mutations in embryos before they are implanted, reducing the risk of passing on known hereditary conditions. This test analyzes embryos to help select those that are less likely to be affected by the specific genetic disorder being tested for. PGD utilizes advanced genetic analysis techniques to provide valuable information for family planning. This specific test focuses on known single-gene disorders. It is typically performed on embryos created through IVF. The test involves analyzing cells from the embryo to check for the presence of the specific genetic mutation identified in the family. This allows couples to make informed decisions about which embryos to transfer, increasing the chances of a healthy pregnancy and reducing the likelihood of having a child affected by the genetic disorder. Discuss with your fertility specialist if PGD is appropriate for your situation.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationConsultation with a physician and genetic counselor is required before testing. This test is performed in conjunction with an IVF cycle. No specific patient preparation is needed for the blood draw, but follow standard instructions provided by the laboratory.

SamplePeripheral blood samples from both parents and, if available, an affected child. Embryo biopsy performed during the IVF cycle.

MethodologySanger Sequencing or other targeted mutation detection methods are used to analyze DNA from parental blood samples and embryo biopsies.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test only detects the specific known mutation being tested for. It does not screen for other genetic disorders or chromosomal abnormalities. Results are dependent on the quality of the sample and the technical accuracy of the testing method. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Preimplantation Genetic Disorder (PGD) testing is a procedure used during IVF to screen embryos for specific genetic conditions before implantation.

PGD is typically recommended for couples undergoing IVF who are known carriers of a specific genetic disorder or have a family history of such a condition.

This test focuses on identifying a known specific mutation associated with a single-gene disorder.

Results indicate whether the tested embryos carry the specific genetic mutation. A genetic counselor can help interpret the results and discuss implications.

PGD significantly reduces the risk of transmitting the specific tested disorder but does not guarantee a completely healthy child, as it only screens for the specific mutation tested.

Please contact your physician or fertility specialist for a referral and to discuss the process. You can also contact our laboratory directly at +254711564616 for more information.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp